All News

03:44pm Mizuho Adjusts Price Target on ResMed to $255 From $300, Maintains Outperform Rating MT
04-09 Resmed Insider Sold Shares Worth $1,125,486, According to a Recent SEC Filing MT
04-08 Citigroup Adjusts Price Target on ResMed to $340 From $345, Maintains Buy Rating MT
04-02 Resmed Insider Sold Shares Worth $450,000, According to a Recent SEC Filing MT
04-01 Resmed to Report Third Quarter Fiscal 2026 Earnings on April 30, 2026 GL
03-11 Resmed Insider Sold Shares Worth $1,252,902, According to a Recent SEC Filing MT
03-11 Baird Adjusts Price Target on ResMed to $272 From $281, Maintains Neutral Rating MT
03-05 Resmed Insider Sold Shares Worth $520,440, According to a Recent SEC Filing MT
03-04 Resmed's Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains out of Reach AQ
03-04 ASX Biggest Gainers MT
03-03 Resmed’s Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach GL
02-26 SomnoMed Limited Announces Management Appointments CI
02-25 Shares of Resmed Fall 3% After Declaring Plan to Open New US Distribution Center MT
02-24 Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana CI
02-24 ResMed to Open New Distribution Center in Indiana MT
02-24 ResMed expands US operations with new distribution center in Indiana RE
02-24 Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana GL
02-11 FA
02-11 Resmed : Introduces Full Face Fabric Mask Designed for Comfort and Improved Sleep Health in the US PU
02-10 Resmed Insider Sold Shares Worth $1,366,436, According to a Recent SEC Filing MT
02-06 Resmed Insider Sold Shares Worth $502,620, According to a Recent SEC Filing MT
02-06 ResMed Chief Legal Officer Sells 50 Common Shares Of Firm MT
02-06 ResMed Director Sells 2,000 Shares MT
02-06 ASX Biggest Gainers MT
02-05 ASX Biggest Gainers MT
No results for this search